Connect with us

Technology

Net Health Looks Ahead to 2025 with Continued Momentum as a Leading Health Tech Partner

Published

on

Business wins, strategic collaborations, and renewed commitment to client partnership highlight a year of transformation

PITTSBURGH, Dec. 20, 2024 /PRNewswire/ — Net Health, a trusted source for specialized software solutions that empower restorative care providers across the continuum of care, is entering 2025 with impressive momentum driven by a year of transformative leadership. Through rebranding initiatives, partnerships and collaborations, and award recognitions, the company has redefined its organizational vision, advanced its mission to deliver impactful healthcare solutions, and solidified its position as a leader in the healthcare technology space.

“As we reflect on a year of growth, it’s clear that Net Health is uniquely positioned to redefine how technology supports providers and patients,” said Ron Books, CEO of Net Health. “From initiating industry-shaping partnerships to delivering effective solutions to clients, our achievements in 2024 are a testament to our team’s dedication. We’re entering 2025 on a high note and remain focused on advancing the future of healthcare through collaboration and a relentless commitment to delivering better outcomes for providers.”

Improving Clarity of Purpose:
In 2024, Net Health renamed its products to make it easier for clients and prospects to understand the solutions it offers. The change reintroduced familiar and trusted names; it reflects Net Health’s commitment to supporting providers with offerings tailored to their unique needs. Changes include:

A return to trusted health tech names:Net Health Optima replaced Therapy for Senior Living and Therapy for Skilled Nursing.Net Health ReDoc replaced Therapy for Hospitals.Net Health TherapySource replaced Therapy for Clinics.Net Health WoundExpert replaced Wound Care. Tissue Analytics was unchanged.Improved clarity:FOTO Analytics replaced FOTO Patient Outcomes.Value-Based Care Solutions replaced PointRight, offering specialized software, analytics, and support to drive success in value-based care for skilled nursing facilities, states, and payers.

The company also unveiled an updated brand and website to more clearly define Net Health.

Building Partnerships:
Net Health continued to forge impactful partnerships and achieve significant milestones. Through collaborations with innovative companies and longstanding clients, Net Health found ways to drive progress in healthcare technology and service delivery.

Artificial Intelligence (AI) integration with Tali.ai: Net Health announced a collaboration with Tali.ai, enabling the company to offer ambient documentation directly inside its products. This collaboration will integrate Tali’s advanced capabilities into select Net Health platforms, including Optima, ReDoc, TherapySource, and WoundExpert. While the partnership is in its early stages, it paves the way for introducing cutting-edge ambient documentation solutions, reinforcing the company’s dedication to improving workflows and patient outcomes.

Data and AI Governance Plan Launched: Net Health introduced a comprehensive Data and AI Governance Plan to ensure the ethical, transparent, and secure use of data and AI technologies. This framework integrates data and AI governance, emphasizing data integrity, compliance with standards like GDPR and HIPAA, and alignment with ONC’s DSI certification requirements. By fostering trust, mitigating risks, and driving operational excellence, this plan enhances the accuracy of AI-driven tools and supports better outcomes for Net Health’s clients.

Accelerating Business Growth:
Net Health renewed and built vital client partnerships with many of the most important providers of restorative care by understanding how technology helps meet their ever-growing needs. Net Health products are built for reimbursement consistency, efficiency gains, and insights that lead to growth. Key wins in 2024 include:

Rock Valley Physical Therapy: Net Health TherapySource is now live across over 60 Rock Valley Physical Therapy locations, supporting over 400 users. This implementation highlights the collaboration and ability of Net Health’s Product Management, Engineering, Client Success, and Implementation teams, delivering a seamless rollout and strong early results. The partnership with Rock Valley has already expanded, with 21st Century joining under the Rock Valley MSA to use TherapySource as its core practice management platform. As part of the Midwest Therapy Network, this addition marks a new phase of growth, with Rock Valley’s influence paving the way for broader TherapySource adoption among independent practices in the network.

Expanded Partnerships and Record-Breaking Bookings: In 2024, the Net Health WoundExpert team achieved a record-breaking month in incremental sales bookings, including wins at notable local and regional hospitals. In addition, the Net Health Tissue Analytics team renewed and expanded its partnership with Intermountain Healthcare, securing a multi-year contract including eight additional hospitals and solidifying its position within a major healthcare network. The team also expanded its presence in post-acute care with new revenue through WoundExpert deployments.

State Medicaid VBP Programs: The Value-Based Care Solutions team achieved a record-breaking October in new bookings for State Medicaid VBP programs in the Hospital and Primary Care settings. In 2024, Net Health Value-Based Care Solutions secured record-breaking new annual recurring revenue through contracts with managed care organizations.

Occupational Health Business Growth: In 2024, Occupational Health surpassed annual sales targets in year-to-date sales bookings, highlighting its success in delivering the technology customers need to be successful and underscoring its commitment to growth. This included numerous client expansions in both Employee Health and Occupational Medicine, strengthening our partnership with clients. The team also focused on migrations of clients to our hosting platform, providing the advantage of security and stability while lowering their total cost of ownership. Occupational Health is growing at a responsible pace that aligns with providing maximum value to clients.

Recognition of Excellence: 
Net Health received several accolades that highlight its work in advancing wound assessment technology.

Merit Awards: Tissue Analytics was recognized with the Gold Award for Mobile Digital Health Resources in the 2024 Merit Awards, honoring excellence across industries.

SaaS Awards: Tissue Analytics was named a finalist for Best SaaS Healthcare Product in the 2024 SaaS Awards.

Strengthening Our Commitment to Clients:
Net Health’s commitment to partnership gained momentum in 2024, helping to expand communications with clients and provide opportunities to influence the direction of product innovation. These initiatives include:

Net Health NEXT: The inaugural Net Health NEXT Client Conference highlighted technology that can better connect patients, payers, and providers; offered hands-on product training forums; and provided insight into what’s to come for electronic health records (EHRs).
 Client and Product Advisory Boards: Net Health sales and product leaders launched Client Advisory Boards and Product Advisory Boards to ensure active collaboration with clients. The boards are an opportunity to help shape product roadmaps and sales/implementation processes.

Coming Soon: In 2025, Net Health will host the second annual Net Health NEXT 2025 Client Conference in Austin, Texas, at The Line Hotel. The two-day event will feature industry insights, hands-on training, and discussions designed to empower practices and enhance patient care.

About Net Health 
Net Health is a trusted source for more than 25,000 healthcare organizations across the continuum of care. Our specialized software solutions enable restorative care providers and their organizations to improve both patient outcomes and financial performance. Over 30 years of expertise in wound care and rehab therapy inform our electronic health record (EHR) software, patient engagement tools, and predictive analytics. Our technology platforms help administrators manage workflow, specialists engage with patients, and executives drive business growth. Net Health is a portfolio company of The Carlyle Group, Level Equity, and Silversmith Capital Partners. Learn more at www.nethealth.com. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/net-health-looks-ahead-to-2025-with-continued-momentum-as-a-leading-health-tech-partner-302337553.html

SOURCE Net Health Systems, Inc.

Continue Reading

Technology

SK hynix Announces 3Q26 Financial Results

Published

on

By

Reports revenues of 104.6155 trillion won, operating profit of 83.3338 trillion won, net profit of 39.7756 trillion won; Quarterly sales surpass 100 trillion won for the first timeSales of HBM4 and high-value-added server products expanded; HBM4 expected to be the mainstream product from the fourth quarterLong-term agreements secured for more than 50% of 2027~2028 production capacity; A structure that reflects market conditions and ensures stable profitabilityMost of the gains from the Kioxia investment to be shared with shareholders, with  approximately 100 trillion won in shareholder returns to be executed this year

SEOUL, South Korea, Oct. 27, 2026 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) announced today that it has recorded 104.6155 trillion won in revenues, 83.3338 trillion won in operating profit (with an operating margin of 80%), and 39.7756 trillion won in net profit (with a net margin of 38%) in the third quarter.

Record quarterly results in both revenue and operating profit and revenue surpasses 100 trillion won for the first time

In a market environment in which prices of key products have risen on the back of growing demand for AI memory, the company once again posted all-time-high quarterly results in both revenue and operating profit, underpinned by the competitiveness of its high-value-added products. In particular, revenue exceeded 100 trillion won for the first time in the company’s history. Revenue and operating profit increased by 32% and 38%, from the previous quarter, respectively.

– Q2 2026: Revenue of 79.3187 trillion won, Operating Profit of 60.5426 trillion won

By product, DRAM results were driven by a significant increase in sales of server DDR5 while HBM4 shipments began in earnest. In NAND, sales of 321-layer TLC eSSD expanded, and high-value-added products for data centers continued to grow across the board.

The company’s financial structure has also become significantly concrete. At the end of the third quarter, cash and cash equivalents stood at 114.5 trillion won, up 26.5 trillion won from the end of the previous quarter, while borrowings decreased by 2.8 trillion won to 15.8 trillion won. As a result, net cash increased to 98.7 trillion won.

Memory supply shortage to persist through 2030

SK hynix analyzed that a virtuous cycle has taken hold in which AI-driven productivity gains and new revenue generation in areas such as software development, customer service, and search lead to greater AI adoption, which in turn drives increased investment in infrastructure. It also projected that, as the drivers of AI investment move beyond the early stage, when a small number of companies accounted for most of it, and broaden to include general enterprises and nation-level initiatives, the global AI data center infrastructure market will continue to grow steadily.

The company likewise expects the memory market to sustain its growth, led in the short term by enterprise and personal AI and, over the mid-to-long term, by physical AI such as autonomous driving and robotics.

The company assessed that supply, on the other hand, is not keeping pace with the growth of the market. Given technical difficulty of leading-edge processes and the long lead time required to build new production facilities, it expects the structure in which demand exceeds supply to persist through 2030.

Expanding production capacity and strengthening product competitiveness to achieve a further step up in growth next year

Building on these favorable conditions, the company plans to accelerate the expansion of production capacity and the strengthening of product competitiveness in order to sustain the current growth momentum, and to scale up revenue and profit one step further next year.

First, the company plans to rapidly increase the portion of its 10nm-class 6th generation (1c) process technology and expand sales of DDR5 and LPDDR5 SOCAMM for AI servers, thereby further strengthening its DRAM portfolio centered on high-value-added products.

To respond to surging HBM demand, the company will ramp up M15X to maximum capacity by the end of the year to increase HBM4 production. Accordingly, the company expects HBM4 to surpass HBM3E in both shipment volume and revenue in the fourth quarter and to establish itself as a mainstream product.

In NAND, the company will raise the ratio of its 321-layer process to more than half of its domestic production capacity in the fourth quarter, and thereby increase the supply of high-performance, high-capacity eSSD. Over the mid-to-long term, the company intends to develop NAND into a core solution that enhances the throughput and economic efficiency of AI services, based on HBF and system optimization technologies.

Long-term agreements secured for more than 50% of 2027~2028 production capacity and the company to drastically expand investment next year

To improve mid-to-long term demand visibility and solidify its growth foundation, SK hynix is expanding long-term agreements (LTAs) with customers. The company has currently signed LTAs with 14 major customers, including leading global cloud service providers (CSPs), and is also proactively discussing with a number of customers the possibility of extending the contract terms, which are typically five years.

The LTA volume secured to date corresponds to more than 50% of total production capacity for 2027 and 2028. In particular, by introducing a mechanism that reflects market conditions within a price range agreed upon with customers, the company has established a structure that secures stable profitability while allowing flexible responses to market changes.

Backed by the demand visibility, the company is also moving to expand its production capabilities. Next year, with the Yongin Phase 1 entering full-scale operation and domestic and overseas infrastructure investment gaining momentum, investment is expected to increase significantly. The company nevertheless plans to adjust the scale and timing of its investment flexibly, after carefully weighing customer demand, product competitiveness, profitability and investment efficiency.

Most of the gains from the Kioxia investment to be shared with shareholders, with approximately 100 trillion won in shareholder returns to be executed this year

As previously indicated in August, SK hynix announced its additional shareholder return plan. For fiscal year 2026, the company will pursue shareholder returns totaling approximately 100 trillion won, comprising cash dividends of 30 trillion won or more and share repurchases and cancellations of 60 trillion won or more in total, including the 40 trillion won announced in August. Through this, the company intends to fulfill its commitment to return 50% or more of free cash flow (FCF). Of this, the 40 trillion won share repurchase announced in August was completed last week, and the shares will be cancelled shortly.

The company also set out its principles: the dividend amount will be determined on the basis of operating results; if significant investment gains arise, they will be returned additionally through special dividends; and share repurchases will continue every quarter.

At today’s meeting, the Board of Directors resolved on a third-quarter cash dividend of 14 trillion won and a share repurchase of 20 trillion won. Of the shares to be repurchased, 10 trillion won, earmarked for shareholder returns, will be cancelled in full, while the remaining approximately 10 trillion won will be used for employee compensation and is not included in the shareholder return total.

The third-quarter dividend is 20,000 won per share, consisting of a 10,000-won dividend reflecting improved earnings and a 10,000 won special dividend that shares the gains from the Kioxia investment. The company has decided to return to shareholders most of the gains realized from its Kioxia investment this year.

SK hynix emphasized that it will deliver stable results based on robust memory demand growth and technological competitiveness and the company will consistently share financial achievements with our shareholders.

 3Q26 Financial Results (K-IFRS)

*Unit: Billion KRW

3Q26

QoQ

YoY

2Q26

Change

3Q25

Change

Revenues

104,615.5

79,318.7

32 %

24,448.9

328 %

Operating Profit

83,333.8

60,542.6

38 %

11,383.4

632 %

Operating Margin

80 %

76 %

3%p

47 %

33%p

Net Income

39,775.6

93,922.6

-58 %

12,597.5

216 %

* Financial information of the earnings is based on K-IFRS

* Please note that the financial results discussed herein are preliminary and speak only as of October 28, 2026. Readers should not assume that this information remains operative at a later time.

* Percentage changes are calculated on the basis of unrounded figures.

Disclaimer

This material has been prepared by the Company for informational purposes only, and the information contained herein has not undergone any separate, independent verification process. No representations or warranties are made regarding the fairness, accuracy, or completeness of the information contained in this material, and such information should not be relied upon. Neither the Company nor its employees bear any civil, criminal, or administrative liability for any damages arising from this material or from its use.

Review of the FY2026 Q3 financial results has not been finalized. Figures in this earnings release are subject to changes during the independent auditing process.

All financial information contained in this document is based on consolidated K-IFRS.

This material contains forward-looking statements, which involve risks and uncertainties. These statements are generally identified words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” and similar expressions, or the negative of such expressions. Forward-looking statements are not guarantees of future performance and are subject to inherent risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. SK hynix undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

This material does not constitute a solicitation for the acquisition or purchase of securities, and no part of this material should serve as the basis for any contract, agreement, or investment decision, nor should it be relied upon in connection therewith.

About SK hynix Inc.

SK hynix Inc., headquartered in Korea, is the world’s top tier semiconductor supplier offering Dynamic Random Access Memory chips (“DRAM”) and flash memory chips (“NAND flash”) for a wide range of distinguished customers globally. The Company’s shares are traded on the Korea Exchange, and the Global Depository shares are listed on the Luxembourg Stock Exchange. Further information about SK hynix is available at www.skhynix.com, news.skhynix.com.

View original content:https://www.prnewswire.com/news-releases/sk-hynix-announces-3q26-financial-results-302921407.html

SOURCE SK hynix Inc.

Continue Reading

Technology

DealLabs Builds Travel AI Data Layer with 280,000 Verified Local Records Across Seven Asian Cities

Published

on

By

SEOUL, South Korea, Oct. 28, 2026 /PRNewswire/ — Seoul-based travel data company DealLabs announced that it has built a database of verified local travel information for seven Asian cities: Seoul, Busan, Tokyo, Osaka, Bangkok, Taipei, and Singapore. As of October 13, the database contained more than 280,000 records, each accompanied by its source and verification date. It powers more than 23,000 guide pages and is published in formats AI systems can read directly.

It covers what travelers look for after arriving: subway station exits, timetables, first and last trains, fares, restaurants, tourist attractions, hospitals, closing days for Singapore’s hawker centers, and business hours for Taipei’s night markets. In Osaka alone, the database contains more than 114,000 records, including more than 42,000 medical institutions and pharmacies and more than 30,000 restaurant permits. In Taipei, it contains more than 63,000 records, including 7,200 station-to-station fares.

The number of times generative AI search and answer services accessed DealLabs’ data increased from around 600 times per day on a seven-day average in late September to more than 11,000 times per day in mid-October, nearly 20-fold in less than a month.

Travel information changes rapidly. On the same day, public event listings and organizers’ own notices gave different end dates for three of 25 pop-up stores in Seoul, up to 10 days apart. Business hours, closing days, last train times, and fares are among the areas where AI travel answers are most frequently inaccurate. DealLabs continuously updates this information using official sources.

All seven cities have AI-ready guide files (llms.txt) and data APIs, while Seoul also provides a standard API specification (OpenAPI). The seven cities are run using a single common engine, allowing a new city to be added simply by incorporating that city’s data and sources.

DealLabs is also piloting “Visit Plan Check,” which checks travel AI itineraries against official sources daily.

Young Cho, founder and CEO of DealLabs, said, “When travelers ask AI a question, what matters is whether the answer is accurate for that city today. We will establish a standard for local data that travel AI can rely on.”

DealLabs plans to expand its coverage to 10 cities by the end of 2026 and to 30 cities, including New York and Paris, by 2028.

For more information, please visit https://deallabs.net.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/deallabs-builds-travel-ai-data-layer-with-280-000-verified-local-records-across-seven-asian-cities-302920425.html

SOURCE DEALLABS

Continue Reading

Technology

Teijin Selects Kharon to Strengthen Export Controls Compliance Across Global Operations

Published

on

By

Kharon ClearView will support Teijin teams in Japan, the United States, and Europe as they navigate Japanese and U.S. export controls requirements.

DENVER, Oct. 28, 2026 /PRNewswire/ — Kharon, a data and technology company that provides risk intelligence solutions to help organizations manage regulatory and business risk, announced that Teijin Limited has selected Kharon ClearView to support its export controls compliance program.

Headquartered in Japan, Teijin operates a global materials business that includes carbon fiber and other advanced materials used in aerospace and industrial applications. Its international operations require compliance teams to navigate export control requirements across multiple jurisdictions, including Japan and the United States.

“As a global company, we need an export controls approach that can support our teams across markets,” said Hitoshi Onodera, General Manager of the Quality Assurance and Security Export Control Department and Manager of the Security Export Control Group at Teijin. “We selected Kharon because of the depth of its risk intelligence, ease of use, and its ability to give our teams greater visibility into the entities and relationships that matter to our reviews. ClearView will help us bring that context consistently into our due diligence processes across our operations.”

Teijin will deploy ClearView across its operations globally. ClearView enables compliance teams to investigate complex entity relationships, including ownership and commercial connections to parties subject to export controls and other trade restrictions.

“Advanced materials companies operate in an increasingly complex export controls environment, where understanding the parties behind a transaction can be just as important as screening the names directly involved,” said Ethan Woolley, Global Director of Strategy at Kharon. “Teijin’s decision to deploy ClearView across its operations reflects the importance of having that level of insight. We are pleased to support its teams as they strengthen their approach to export controls compliance.”

About Teijin

Teijin Limited is a Japan-based global technology company providing products and solutions across advanced materials, healthcare, and other technology-driven fields. Founded in 1918, Teijin’s businesses include high-performance materials such as aramid fibers, carbon fibers, and composites, serving applications across mobility, infrastructure, industry, and other markets. The Teijin Group comprises 126 companies and approximately 15,700 employees worldwide.

For more information, visit https://www.teijin.co.jp/.

About Kharon

Kharon’s intelligence supports compliance, trade, risk, and national security programs at organizations around the world, including seven of the 10 largest U.S. banks, six of the 10 largest EU banks, and over 35 Fortune 100 companies. Kharon’s data can also be directly integrated with AI applications and agentic operations through Kharon’s API, MCP, and agent gateway infrastructure, enabling organizations to embed Kharon’s sourced, structured insights into automated workflows alongside their teams.

Visit kharon.com and follow Kharon on LinkedIn to stay connected.

Media contact

Kharon
media@kharon.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/teijin-selects-kharon-to-strengthen-export-controls-compliance-across-global-operations-302921369.html

SOURCE Kharon

Continue Reading

Trending